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Increased expression of TGF-b1 but not of its receptors con- obstructed kidney (OBK) at three days after unilateral
tributes to human obstructive nephropathy. ureteral obstruction (UUO), and that the level continued
Background. Previous studies have revealed an increased to be elevated until the 14th day of UUO [1]. Otherexpression of transforming growth factor-b1 (TGF-b1) and
investigators showed an increase in TGF-b1 mRNA asdeposition of extracellular matrix in the kidney of animals with
early as 12 hours of UUO [3]. Thus, an increase in TGF-b1ureteral obstruction. However, these relationships have not
been elucidated in the hydronephrotic kidney of humans. contributes to tubulointerstitial fibrosis in both acute and
Methods. We analyzed the tissue expression of extracellular chronic phases of obstructive nephropathy. Palmer et al
matrix proteins, TGF-b1, and its receptors in the human kidney demonstrated that the urinary TGF-b1 concentration inwith ureteral obstruction by immunohistochemistry and re-
the renal pelvis of children with congenital hydronephro-verse transcription-polymerase chain reaction (RT-PCR). Ob-
sis was significantly higher than that in the bladder urinestructed kidneys (OBKs) were obtained from patients with
ureteral tumors. A kidney specimen from patients with a renal of the same group or that in the control group [6]. Thus,
tumor was used as control (CNKs). it is conceivable that in humans, TGF-b1 contributes to
Results. The interstitial volume was significantly increased renal fibrosis in the setting of acute or chronic ureteralin OBKs in comparison with CNKs. OBKs showed increased
obstruction by similar mechanisms to those described indeposition of collagen types I and IV and fibronectin in the
the experimental animal models.renal interstitium. RT-PCR revealed overexpression of colla-
gen a1(IV) mRNA and fibronectin mRNA in OBKs. OBKs Although several receptors for TGF-b have been iden-
showed a significantly increased mRNA expression of TGF-b1 tified, an interaction between type I and type II receptors
in comparison with CNKs. The immunoreactivity for TGF-b1
has an important role in signal transduction through theincreased markedly in the interstitium of OBKs. There was a
serine/threonine kinase domain [7, 8]. However, theresignificant correlation between the TGF-b1 mRNA level and
the interstitial volume. However, there was no significant dif- are few reports describing the expression of TGF-b re-
ference between OBKs and CNKs in the relative mRNA level ceptors in renal injury. Tamaki et al found mRNA up-
nor in immunoreactivity for TGF-b receptors. regulation of both TGF-b and type II receptors in ani-
Conclusions. These data suggest that TGF-b1 may contribute
mals with adriamycin-induced nephropathy, a model ofto the interstitial fibrosis found in the human kidney with ureteral
glomerulosclerosis and interstitial fibrosis [9]. In thisobstruction, mainly because of an increase in the expression of
this cytokine without significant changes to its receptors. model, up-regulation of both the ligand (TGF-b1) and its
receptor may have a role in interstitial fibrosis. Recently,
Sutaria et al demonstrated up-regulation of TGF-b type
Animal experimental models have elucidated the I and type II receptors in both obstructed and contralat-
mechanisms of tubulointerstitial injury in the kidney with eral kidneys of rats with UUO [10].
ureteral obstruction. Transforming growth factor-b1 This study was therefore designed to analyze the ex-
(TGF-b1) is a major cytokine involved in this injury pression of extracellular matrix (ECM) proteins and
[1–5]. These authors first demonstrated that TGF-b1 TGF-b1 and to investigate whether receptors for TGF-b
mRNA levels are up-regulated in the renal cortex of the have a role in obstructive nephropathy in the human
kidney with ureteral obstruction.
Key words: tubulointerstitial disease, cytokine, unilateral ureteral ob-
struction, fibrosis, renal injury, hydronephrosis.
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cause of transitional cell carcinoma of the ureter (5 males The primary antibodies used are listed in Table 1.
TGF-b1 antibody (Ab96), TGF-b receptor type I anti-and 4 females, mean age 68.4 years, range 50 to 81 years).
Ultrasonography and/or intravenous urography revealed body (VPN), and TGF-b receptor type II antibody (DRL)
recognize LAPs of TGF-b1 and intracellular domains ofmild to severe degrees of hydronephrosis. However, we
could not confirm the onset of ureteral obstruction be- TbRI and TbRII, respectively. The properties of these
antibodies have been described previously [13–15]. Thecause all patients had shown hydronephrosis at the time
of their visit to the hospital. The control kidneys (CNKs), second antibodies were peroxidase-conjugated sheep
antimouse IgG, F(ab9)2 and donkey antirabbit IgG,which did not show hydronephrosis, were obtained from
eight patients who underwent nephrectomy because of F(ab9)2 (Amersham, Buckinghamshire, UK). Rabbit im-
munoglobulin or mouse IgG1 (Dako, Tokyo, Japan) wasrenal cell carcinoma (6 males and 2 females, mean age
52.8 years, range 27 to 69 years). We obtained tissue used as a negative control.
from morphologically normal areas of these CNKs. For
Characterization and quantitation of mRNAhistological studies, a surgical specimen of each kidney
by RT-PCRwas fixed in 4% paraformaldehyde (PFA) for two to
four hours at 48C, washed in phosphate-buffered saline Total RNA was extracted from the renal cortex by
RNAzol B (Biotecx Laboratories, Houston, TX, USA)(PBS), immersed in 10% and 20% sucrose/PBS each for
four hours, embedded in OCT compound, and frozen in and dissolved in TE buffer [10 mm Tris, 1 mm ethylenedi-
aminetetraacetic acid (EDTA)]. cDNA was synthesizedliquid nitrogen. PFA-fixed, paraffin-embedded sections
were also prepared for conventional histological exami- from 8 mg of each total RNA using oligo (dT) 15 primer.
The mixture of RNA and oligo dT was incubated for 10nation. For RNA extraction, the renal cortex was dis-
sected, immediately frozen, and stored at 2708C until use. minutes at 658C and chilled on ice. The reverse tran-
scriptase (RT) buffer, 5 mm MgCl2, 20 U of RNase inhibi-
Morphometric analysis of interstitial volume tor, 1 mm dNTP and 15 U of AMV RT (Promega, Madi-
son, WI, USA) were added, incubated at 428C for 60A standard point-counting method was used to quanti-
tate the interstitial volume on the stained sections, as minutes, heated to 958C for three minutes, and chilled
on ice. Three microliters of each cDNA were used fordescribed previously [11, 12]. We used a grid containing
36 sampling points engraved on an eyepiece and counted polymerase chain reaction (PCR). To each cDNA was
applied 47 ml of reaction mixture containing PCR bufferthe points falling on the renal interstitium, including
tubular basement membrane, directly in the microscopic (50 mm KCl, 10 mm Tris-HCl, and 1.5 mm MgCl2), 200
mm of each dNTP, and 50 pmol of oligonucleotide prim-field under 3200 magnification in consecutive nonover-
lapping fields (over 50 fields). We determined the per- ers for TGF-b1, TbRI, TbRII, and collagen a1(IV), 25
pmol of fibronectin primer, or 20 pmol of glyceralde-centage of the total points/36 3 the number of counted
fields as the volume fraction (Vv). hyde-3-phosphate dehydrogenase (GAPDH) primer.
The mixture was first incubated in a thermal cycler at
Immunohistochemical study 728C, and then 1.25 U of Taq polymerase (Pharmacia
Biotech, Milwaukee, WI, USA) was added to each tube.Paraffin sections (3 mm in thickness) were deparaffin-
ized and used for immunostaining of fibronectin and PCR was carried out with a Perkin Elmer Cetus DNA
Thermal Cycler using the following programs (optimalcollagen types I and IV. The deparaffinized sections were
treated in 0.05 m Tris-HCl, pH 7.6, and digested with cycles were developed previously for each primer): 948C
(1 min), 608C (1 min), and 728C (1 min) for TGF-b10.1% trypsin in 0.1% CaCl2/0.05 m Tris-HCl, pH 7.6, for
30 minutes at room temperature. Frozen sections (4 mm (30 cycles), collagen a1(IV) (26 cycles), fibronectin (28
cycles), and GAPDH (26 cycles); 948C (1 min), 658C (1in thickness) were used for immunostaining of latency-
associated peptide (LAP) for TGF-b1, and TGF-b type I min), and 728C (1 min) for TbRI (34 cycles) and TbRII
(32 cycles). The primers were designed according to the(TbRI) and type II (TbRII) receptors. The sections were
washed in PBS and immersed in 10% sheep or donkey human cDNA sequences for TGF-b1, TbRI, TbRII, col-
lagen a1(IV), fibronectin, and GAPDH (Table 2). Fibro-normal serum to block nonspecific binding sites for 30
minutes at room temperature and were then incubated nectin primers were designed to flank the EDA region
of the human cDNA. The resultant sizes of PCR productsin the primary antibody overnight at 48C. The sections
were immersed in 0.03% H2O2 in methanol to block were 496 bp and 226 bp of EDA positive (EDA1) and
EDA negative (EDA2) variants, respectively. PCRendogenous peroxidase activity and were then incubated
in the secondary antibody (1:100 dilution) for one hour products were sequenced using a dGTP BigDye Termi-
nator Cycle Sequencing kit and an ABI PRISM 310at room temperature. The sections were then washed in
PBS, followed by incubation with 0.005% H2O2/0.03% Genetic Analyzer (PE Applied Biosystems, Foster City,
CA, USA) to confirm the identity of PCR product asdiaminobenzidine (DAB) in 0.05 m Tris-HCl, pH 7.6,
and were counterstained with 4% methylgreen. target cDNA. After amplification, 15 ml of each PCR
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Table 1. Antibodies used in the present study
Antibody Clone Final dilution Source
Fibronectin Polyclonal 1:1000 Dako, Tokyo, Japan
Collagen type I Polyclonal 1:200 Chemicon, Temecula, USA
Collagen type IV CIV22 1:100 Dako, Glostrup, Denmark
TGF-b1 (Ab96) Polyclonal 1:200 The Cancer Institutea
TGF-b receptor type I (VPN) Polyclonal 1:50 The Cancer Institutea
TGF-b receptor type II (DRL) Polyclonal 1:10 The Cancer Institutea
a These antibodies were kindly provided by Dr. K. Miyazono, Department of Biochemistry, The Cancer Institute, Tokyo, Japan
Table 2. Primer sequences
Gene Primers Size Reference
TGF-b1 (antisense) 59-T TGCAGTGTGT TAT CCGTGC TGT C 187 bp [16]
(sense) 59-CAGAAATACAGCAACAAT T CC TGG
TbRI (antisense) 59-GACAGTGCGGT TGTGGCAGAT 354 bp [14]
(sense) 59-TGT T T C TGCCACC T C TGTAC
TbRII (antisense) 59-T C T CAAAC TGC T C TGAAGTGT 598 bp [17]
(sense) 59-ACC T CCAT C TGTGAGAAGCC
Collagen a1(IV) (antisense) 59-GGGTGTGT TAGT TACGCAAAT 434 bp [18]
(sense) 59-GC TGTGGAT CGGC TAC T C T T
Fibronectin (antisense) 59-T T C T T T CAT TGGT CCGGT C T T 496 bp [19]
(sense) 59-GCAGCCCACAGTGGAGTATGT 226 bp
GAPDH (antisense) 59-T CCACCACCC TGT TGC TGTA 527 bp [20]
(sense) 59-T CC TGCACCACCAAC TGC T T
product were electrophoresed through 2.0% agarose gel volume. The interstitial volume of OBKs was signifi-
cantly greater than that of CNKs (40 6 19.4% vs. 16 6with ethidium bromide (0.5 mg/ml). The gel was photo-
graphed with Polaroid type 665 negative film over ultra- 2.3%, P , 0.01). There was a correlation between the
degree of hydronephrosis assessed by ultrasonographyviolet light. The negative film was developed, and the
bands on the film were scanned by densitometry (Molec- and the interstitial volume in the OBK group. However,
there was no significant correlation between the intersti-ular Analyst software; Bio-Rad, Richmond, CA, USA).
The ratio of optical density of each target mRNA against tial volume and the ages of the patients in either the
OBK or CNK groups.that of GAPDH mRNA was determined as a relative
mRNA level.
Immunostaining for ECM proteins
Statistical analysis Figure 2 demonstrates the immunohistochemical ap-
pearance of ECM proteins. Fibronectin was weaklyData are shown as mean 6 sd and were analyzed
by unpaired Student’s t-test. The relationship between stained and confined to the peritubular space in the renal
cortex of CNKs (Fig. 2A). OBKs showed a remarkableTGF-b1 mRNA levels and the interstitial volume was
examined by linear regression analysis. increase in fibronectin in the widened interstitial space,
but not in the tubular basement membrane (Fig. 2B).
Collagen type I (as with fibronectin) was increased in
RESULTS
the interstitium of OBKs (Fig. 2D) in comparison with
Morphology of renal cortex that of CNKs (Fig. 2C). Collagen type IV was confined to
tubular basement membranes and peritubular capillariesFigure 1A shows the renal cortex of a CNK (40-year-
old male) stained with periodic acid-Schiff. The peritubu- and was not found in the interstitial space in CNKs (Fig.
2E). In contrast, OBKs showed an increased depositionlar space was narrow, and there were few interstitial
cells. In contrast to this, the OBK (70-year-old male) of collagen type IV in both the interstitium and the
tubular basement membrane (Fig. 2F).showed an increased interstitial space with deposition of
ECM and a marked atrophy of cortical tubules (Fig. 1B).
mRNA expression for collagen a1(IV) and fibronectin
Interstitial volume of renal cortex We examined gene expression of collagen type IV
as a membranous ECM and that of fibronectin as anThe range of interstitial volume was 13.1 to 19.1% in
CNKs and 14 to 68% in OBKs. Eight of nine OBKs had interstitial ECM. The representative PCR products of
collagen a1(IV), fibronectin, and GAPDH are shown inover 20%, and five of these had over 40% interstitial
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Fig. 1. Morphology of the renal cortex of control kidney (CNK; 40-year-old male; a) and obstructed kidney (OBK; 70-year-old male; b; PAS
staining; original magnification 3200).
Figure 3. The GAPDH level was approximately the same not consistent with the region of increased deposition of
in every case. OBKs showed higher collagen a1(IV) ECM.
mRNA levels than CNKs. Both EDA1 and EDA2 vari-
mRNA expression for TGF-b1, TbRI, and TbRIIants of fibronectin mRNA were increased in the OBKs
as compared with CNKs, although the increase in expres- We first amplified cDNA synthesized with or without
sion was slight in two cases of OBKs. The ratio of EDA1 RT from the total RNA of CNK to confirm the specificity
to EDA2 mRNA level was not different between CNKs of PCR primers. The PCR product of the predicted size
and OBKs. was obtained by using cDNA synthesized with RT,
whereas no bands were seen in the PCR product from
Immunostaining for TGF-b1, TbRI, and TbRII
cDNA synthesized without RT. Figure 5 demonstrates
Ab96 recognizes TGF-b1 LAP either with or without representative PCR products of TGF-b1, TbRI, TbRII,
mature TGF-b1 and LAP bound to latent TGF-b–binding and GAPDH obtained from OBKs (2 cases) and CNKs
protein [13]. Figure 4 a and b demonstrate the immuno- (2 cases). GAPDH mRNA levels were not different
staining of TGF-b in the renal cortex. Immunoreactivity among these four cases. The amount of TGF-b1 PCR
for TGF-b was observed in the interstitial space in both product was slightly greater in OBKs than in CNKs.
CNKs and OBKs. In CNKs, TGF-b was seen around OBKs showed approximately the same mRNA levels of
the peritubular capillaries, but not in the renal tubular TbRI and TbRII as CNKs. We evaluated the relative
cells or in glomeruli (Fig. 4a). OBKs showed intense mRNA levels by calculating the ratio of TGF-b1, TbRI,
immunoreactivity for TGF-b in the increased interstitial
or TbRII mRNA against GAPDH mRNA (Fig. 6). The
space, especially around interstitial cells, but not in renal
relative amount of TGF-b1 mRNA in OBKs was signifi-
tubules (Fig. 4b). OBKs with 14% interstitial volume
cantly greater than that in CNKs (0.93 6 0.138 vs. 0.69 6showed the same immunoreactivity for TGF-b as CNKs.
0.186, P , 0.05). However, the mRNA levels of TbRIThere was no detectable difference in the pattern of
and TbRII were not significantly different betweenTGF-b1 distribution among OBKs.
OBKs and CNKs.VPN staining produced positive signals for TbRI in
collecting ducts and distal tubules and showed no quanti-
Correlation between interstitial volume and TGF-b1tative differences between CNK (Fig. 4c) and OBK (Fig.
mRNA level of obstructed kidneys4d). DRL staining for TbRII exhibited the same pattern
Based on the assumption that the interstitial volumeof distribution as TbRI. In CNKs, TbRII was seen in
of the renal cortex in OBKs may reflect the degree ofcollecting ducts and distal tubules, whereas in some spec-
fibrogenesis in the interstitium, we analyzed the relation-imens, TbRII was present weakly beneath the basement
ship between interstitial volume (Vv) and the ratio ofmembrane of proximal tubules (Fig. 4e). In OBKs, the
OBK TGF-b1 mRNA (Fig. 7), revealing a positive corre-pattern was approximately the same as in CNKs (Fig. 4f).
lation (r 5 0.799, P , 0.01, Pearson). This positive corre-No immunoreactivity for TbRI or TbRII was observed in
lation was confirmed with the addition of data frominterstitial cells or glomeruli either in CNKs or OBKs.
The localization of TbRI- and TbRII-positive cells was CNKs (data not shown).
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Fig. 2. Immunostaining for extracellular matrix (ECM) proteins in the renal cortex of CNK (a, c, and e) and OBK (b, d, and f ). (a and b)
Fibronectin. (c and d) Collagen type I. (e and f) Collagen type IV. Original magnification 3400.
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Fig. 3. Representative polymerase chain re-
action (PCR) products of collagen a1(IV),
fibronectin, and GAPDH in CNKs (1–4) and
OBKs (5–8). Fibronectin shows two mRNA
variants of EDA1 (496 bp) and EDA2 (226
bp). M, DNA size marker.
DISCUSSION TGF-b up-regulates both fibronectin isoforms or that
EDA2 mRNA is regulated by other cytokines in theWe have demonstrated that the renal cortex of OBKs
kidneys of humans with obstructive nephropathy.shows variable degrees of increase in the relative volume
The mechanisms underlying the progression of tubulo-of the cortical interstitium from values in the normal
interstitial injuries have been studied by many investiga-range up to 68%, whereas the interstitial volume of nor-
tors. TGF-b is the major cytokine promoting the deposi-mal CNKs was 13 to 19%. The variance of the increase
tion of ECM during fibrogenesis in renal injury [reviewedof the interstitial volume of OBKs may be due to the
in 26]. However, there have been few reports concerningdegree and duration of ureteral obstruction because
TGF-b in the onset of kidney disease in humans [27, 28].there was a correlation between the degree of hydrone-
We found an increase in the expression of TGF-b1phrosis assessed by ultrasonography and the interstitial
mRNA and protein in human kidneys with ureteral ob-volume. In the experimental model of UUO, it has been
struction. A positive correlation between TGF-b1 mRNAshown that interstitial volume increases in OBKs of rats
expression and the interstitial volume suggests that sus-as early as three days after complete ureteral ligation
tained TGF-b1 up-regulation results in severe renal fi-[12] and that in the chronic phase, the interstitial volume
brosis in OBKs in humans. The expansion of the intersti-in OBKs increased by 40% from a value of 2.8% in the
tial space was due mainly to the accumulation of ECMkidney of normal rabbits [4].
proteins in the interstitium. Thus, these data suggest thatThis immunohistochemical study revealed that the
TGF-b1 contributes to interstitial fibrosis in the chronicexpansion of the cortical interstitium of OBKs was partly
phase of human obstructive nephropathy.due to the increased deposition of both interstitial and
There is still controversy concerning the cellular sourcesmembranous ECM. Fibronectin and collagen type I were
of TGF-b1 in tubulointerstitial fibrosis during UUO.confined to the cortical interstitium in both CNKs and
Macrophages are potential sources of TGF-b1 in OBKs.OBKs, whereas collagen type IV increased in both the
It has been shown that monocytes/macrophages infiltrateinterstitium and the basement membrane of OBKs.
the renal interstitium of OBKs as early as four hours ofmRNA expression for collagen type IV and fibronectin
UUO [29]. Diamond et al demonstrated that intracellu-was up-regulated in OBKs as compared with CNKs. Fi-
lar TGF-b1 was positive in the monocytes/macrophagesbronectin mRNA precursor is alternatively spliced to
that had infiltrated the renal interstitium of OBKs, andyield several isoforms [21]. It has been shown that TGF-b
that there was a significant correlation between the num-preferentially up-regulates the EDA-containing isoform
ber of infiltrating mononuclear cells and the TGF-b1(both mRNA and protein) in cultured human fibroblasts
mRNA level [3]. Other investigators found immunoreac-[22, 23]. Viedt, Burger, and Hansch demonstrated that
tivity for TGF-b1 in interstitial mononuclear cells in thehuman tubular epithelial cells exhibit a preferential in-
OBKs 24 hours after the commencement of UUO [5].crease in EDA1 mRNA after stimulation by TGF-b [24,
They also detected TGF-b1 in the juxtaglomerular appa-25]. In the experimental UUO model, OBKs overex-
ratus, peritubular capillaries, and tubular cells. Yama-pressed EDIIIA (the rat equivalent to human EDA)-
moto et al demonstrated that in an anti-mesangial modelpositive mRNA but not the ED-IIIA-negative variant
[1]. However, in this study, both EDA1 and EDA2 of serum nephritis, TGF-b–positive interstitial mononu-
clear cells exhibit immunoreactivity for fibroblastic/myo-variants increased in OBKs as compared with CNKs.
The ratio of EDA1 to EDA2 mRNA level was not fibroblastic cells but not for monocytes/macrophages
[30]. They also showed an increase in TGF-b transcriptsdifferent between CNKs and OBKs. Thus, it may be that
Kaneto et al: TGF-b1 in human obstructive nephropathy 2143
Fig. 4. Immunostaining for TGF-b1 (a and b), TbRI (c and d ) and TbRII (e and f ) in the renal cortex of CNK (a, c, and e) and OBK (b, d,
and f; original magnification 3400).
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Fig. 5. Representative PCR products of
TGF-b1, TbRI, and TbRII in OBKs (1, 2)
and CNKs (3, 4). M, DNA size marker.
Fig. 6. Relative amounts of TGF-b1, TbRI,
and TbRII mRNA in OBKs and CNKs. The
vertical axis expresses mRNA as a ratio of
GAPDH mRNA (N 5 8 for CNKs and N 5
9 for OBKs). #P , 0.05 vs. CNK.
al reported that TGF-b1 was positive both in tubular
epithelial cells and in interstitial cells in adriamycin ne-
phropathy [9]. They suggested that only a part of the
population of infiltrating macrophages is the source of
TGF-b1 because the number of ED-1–positive cells ex-
ceeded that of TGF-b1–positive cells. Thus, both resi-
dent renal tubular cells and interstitial cells, including
infiltrating mononuclear cells, may be responsible for
TGF-b production in experimental model.
Transforming growth factor-b is synthesized in a pre-
cursor form and is cleaved to active TGF-b by a LAP.
Niemir et al found overexpression of LAP but a low
amount of active TGF-b1 in the interstitium of human
IgA glomerulonephritic kidneys and suggested that con-
version to active TGF-b from latent TGF-b was limitedFig. 7. Correlation between the relative amount of TGF-b1 mRNA
and the interstitial volume (Vv) of OBKs. There is a significant correla- in this model [27]. In this investigation, we used an anti-
tion. body that recognizes LAP with or without active
TGF-b1. LAP was positive mainly in the interstitium,
but not in the interstitial mononuclear cells or in renal
tubular cells, in both CNKs and OBKs. There was noin both glomeruli and the renal interstitium of the af-
difference in the pattern of TGF-b1 distribution amongfected kidney. Renal tubular cells may be responsible
OBKs. Because latent TGF-b is produced in responsefor production of TGF-b1 because an up-regulation of
to up-regulation of TGF-b transcription in the OBK, itTGF-b1 mRNA was observed in renal cortical tubules
rather than glomerular cells of OBKs [1]. Tamaki et is likely that latent TGF-b is produced and promptly
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